Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Exchange and Glucocorticoid Dosing in ANCA Associated Vasculitis
2009-013220-24Phase 4Terminated
- Sponsor
- Addenbrooke's Hospital
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prednisolone and prednisone in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) (4 arms), sponsored by Addenbrooke's Hospital. Primary endpoint: Composite of all-cause mortality or end-stage kidney failure. Started Sep 2009; status: terminated.
02
Drugs
prednisoloneprednisone
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on 2009-013220-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013220-24.